DrugMapper
Browse
Therapeutic Area
CANCER (51)
CARDIOVASCULAR (45)
DENTISTRY (2)
DERMATOLOGY (31)
DIABETES DRUGS & ENDOCRINOLOGY (61)
EMERGENCY MEDICINE (3)
ENT (5)
EYE (23)
GASTROINTESTINAL (29)
HEMATOLOGY (23)
MUSCULOSKELETAL (28)
NEUROLOGY DRUGS & NERVOUS SYSTEM (50)
PEDIATRICS (27)
PHARMACOLOGY (8)
PREGNANCY AND GYNECOLOGY (30)
RESPIRATORY (42)
RHEUMATOLOGY (19)
OTHER (1482)
Therapeutic Indication
Adverse Reaction (System Organ Classification)
Mechanism of Action
Primary Target
Target Level
Level 1
Level 2
Level 3
Level 4
Level 5
Level 6
Active Pharmaceutical Ingredients (APIs)
Small Molecules
ProDrugs
Antibodies
CNS drugs
Metabolites
Search
Therapeutic Indication
Adverse Reaction (System Organ Classification)
Mechanism of Action
Target Sequence
Chemical Structure
Physicochemical Properties
Analyze
Networks
Chemical Similarity
Scaffold Similarity
KNIME workflow
Downloads
Web services
Bulk Downloads
About
DrugMapper FAQs
Data Sources
Contact Us
Display Options:
Drug type
Therapeutic Area
Route of administration
Mechanism of Action
Indication
Status
Total:
10647
BENAZEPRIL HYDROCHLORIDE; HYDROCHLOROTHIAZIDE
4
Combination
Approved
OTHER
ORAL
Unknown
Unknown
BENAZEPRIL HYDROCHLORIDE; HYDROCHLOROTHIAZIDE
×
Maximum Phase:
4
First Approval:
None
UNII:
Molecule Type:
Combination
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
HYDROCHLOROTHIAZIDE; PINDOLOL
4
Combination
Approved
OTHER
ORAL
Unknown
Unknown
HYDROCHLOROTHIAZIDE; PINDOLOL
×
Maximum Phase:
4
First Approval:
None
UNII:
Molecule Type:
Combination
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
HEPARIN
4
Oligosaccharide
Approved
Unknown
Unknown
Diabetes Mellitus, Type 2; Severe Acute Respiratory Syndrome
Unknown
HEPARIN
×
Maximum Phase:
4
First Approval:
None
UNII:
T2410KM04A
Molecule Type:
Oligosaccharide
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
MAGNESIUM
4
Small molecule
Approved
Unknown
Unknown
Anemia, Sickle Cell; Chemical and Drug Induced Liver Injury; Stomatitis; Pain; Uterine Cervical Neoplasms
Unknown
MAGNESIUM
×
Maximum Phase:
4
First Approval:
None
UNII:
I38ZP9992A
Molecule Type:
Small molecule
Molecular Formula:
H2Mg
Molecular Weight:
26.32
AlogP:
None
PSA:
None
HBD:
None
HBA:
#RotB:
None
Source:
BEPHENIUM HYDROXYNAPHTHOATE
4
Small molecule
Approved
Unknown
Unknown
Unknown
Unknown
BEPHENIUM HYDROXYNAPHTHOATE
×
Maximum Phase:
4
First Approval:
None
UNII:
47RU9546DX
Molecule Type:
Small molecule
Molecular Formula:
C28H29NO4
Molecular Weight:
443.54
AlogP:
None
PSA:
None
HBD:
None
HBA:
#RotB:
None
Source:
THYROID
4
Unknown
Approved
Unknown
Unknown
Diabetes Mellitus, Type 2; Down Syndrome; Heart Failure; Thyroid Neoplasms
Unknown
THYROID
×
Maximum Phase:
4
First Approval:
None
UNII:
None
Molecule Type:
Unknown
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
BENDROFLUMETHIAZIDE; NADOLOL
4
Combination
Approved
OTHER
ORAL
Unknown
Unknown
BENDROFLUMETHIAZIDE; NADOLOL
×
Maximum Phase:
4
First Approval:
None
UNII:
Molecule Type:
Combination
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
6-THIOGUANINE
4
Unknown
Approved
Unknown
Unknown
Unknown
Unknown
6-THIOGUANINE
×
Maximum Phase:
4
First Approval:
None
UNII:
Molecule Type:
Unknown
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
SUGAR, INVERT
4
Unknown
Approved
Unknown
Unknown
Varicose Veins
Unknown
SUGAR, INVERT
×
Maximum Phase:
4
First Approval:
None
UNII:
None
Molecule Type:
Unknown
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
CARBETAPENTANE CITRATE
4
Small molecule
Approved
Unknown
Unknown
Sinusitis
Sigma opioid receptor agonist
CARBETAPENTANE CITRATE
×
Maximum Phase:
4
First Approval:
None
UNII:
4SH0MFJ5HJ
Molecule Type:
Small molecule
Molecular Formula:
C26H39NO10
Molecular Weight:
525.6
AlogP:
3.4
PSA:
38.77
HBD:
0.0
HBA:
#RotB:
10.0
Source:
TRELAGLIPTIN
4
Small molecule
Approved
Unknown
Unknown
Diabetes Mellitus, Type 2
Unknown
TRELAGLIPTIN
×
Maximum Phase:
4
First Approval:
None
UNII:
Q836OWG55H
Molecule Type:
Small molecule
Molecular Formula:
C18H20FN5O2
Molecular Weight:
357.39
AlogP:
0.53
PSA:
97.05
HBD:
1.0
HBA:
#RotB:
3.0
Source:
CEFTIBUTEN DIHYDRATE
4
Small molecule
Approved
ENT; IMMUNE SYSTEM; OTHER; RESPIRATORY
ORAL
Unknown
Unknown
CEFTIBUTEN DIHYDRATE
×
Maximum Phase:
4
First Approval:
None
UNII:
Molecule Type:
Small molecule
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
CALCIUM CHLORIDE; DEXTROSE; MAGNESIUM CHLORIDE; POTASSIUM CHLORIDE; SODIUM ACETATE; SODIUM CHLORIDE; SODIUM LACTATE
4
Combination
Approved
OTHER
INJECTION
Unknown
Unknown
CALCIUM CHLORIDE; DEXTROSE; MAGNESIUM CHLORIDE; POTASSIUM CHLORIDE; SODIUM ACETATE; SODIUM CHLORIDE; SODIUM LACTATE
×
Maximum Phase:
4
First Approval:
None
UNII:
Molecule Type:
Combination
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
VERNAKALANT
4
Small molecule
Approved
Unknown
Unknown
Atrial Flutter; Atrial Fibrillation; Arrhythmias, Cardiac
Unknown
VERNAKALANT
×
Maximum Phase:
4
First Approval:
None
UNII:
9G468C8B13
Molecule Type:
Small molecule
Molecular Formula:
C20H31NO4
Molecular Weight:
349.47
AlogP:
2.64
PSA:
51.16
HBD:
1.0
HBA:
#RotB:
7.0
Source:
SODIUM BROMIDE
4
Small molecule
Approved
Unknown
Unknown
Unknown
Unknown
SODIUM BROMIDE
×
Maximum Phase:
4
First Approval:
None
UNII:
LC1V549NOM
Molecule Type:
Small molecule
Molecular Formula:
BrNa
Molecular Weight:
102.89
AlogP:
None
PSA:
None
HBD:
None
HBA:
#RotB:
None
Source:
SODIUM PHOSPHATE P-32
4
Small molecule
Approved
OTHER
INJECTION; ORAL
Unknown
Unknown
SODIUM PHOSPHATE P-32
×
Maximum Phase:
4
First Approval:
None
UNII:
Molecule Type:
Small molecule
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
LETROZOLE; RIBOCICLIB SUCCINATE
4
Combination
Approved
Unknown
ORAL
Unknown
Unknown
LETROZOLE; RIBOCICLIB SUCCINATE
×
Maximum Phase:
4
First Approval:
None
UNII:
Molecule Type:
Combination
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
IGOVOMAB
4
Antibody
Approved
Unknown
Unknown
Unknown
Mucin-16 binding agent
IGOVOMAB
×
Maximum Phase:
4
First Approval:
None
UNII:
None
Molecule Type:
Antibody
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
ARZOXIFENE
4
Small molecule
Approved
Unknown
Unknown
Osteoporosis; Breast Neoplasms; Osteoporosis, Postmenopausal
Estrogen receptor modulator
ARZOXIFENE
×
Maximum Phase:
4
First Approval:
None
UNII:
E569WG6E60
Molecule Type:
Small molecule
Molecular Formula:
C28H29NO4S
Molecular Weight:
475.61
AlogP:
6.94
PSA:
51.16
HBD:
1.0
HBA:
#RotB:
8.0
Source:
ALOGLIPTIN; METFORMIN HYDROCHLORIDE
4
Combination
Approved
Unknown
ORAL
Unknown
Unknown
ALOGLIPTIN; METFORMIN HYDROCHLORIDE
×
Maximum Phase:
4
First Approval:
None
UNII:
Molecule Type:
Combination
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
ALISKIREN HEMIFUMARATE; AMLODIPINE BESYLATE
4
Combination
Approved
CARDIOVASCULAR; OTHER
ORAL
Unknown
Unknown
ALISKIREN HEMIFUMARATE; AMLODIPINE BESYLATE
×
Maximum Phase:
4
First Approval:
None
UNII:
Molecule Type:
Combination
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
ALIPOGENE TIPARVOVEC
4
Gene
Unknown
Unknown
Unknown
Hyperlipoproteinemia Type I; Cardiovascular Diseases
Triglyceride hydrolytic enzyme
ALIPOGENE TIPARVOVEC
×
Maximum Phase:
4
First Approval:
None
UNII:
20OK4AFR4Y
Molecule Type:
Gene
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
BENZARONE
4
Small molecule
Approved
Unknown
Unknown
Unknown
Unknown
BENZARONE
×
Maximum Phase:
4
First Approval:
None
UNII:
23ZW4BG89C
Molecule Type:
Small molecule
Molecular Formula:
C17H14O3
Molecular Weight:
266.3
AlogP:
3.93
PSA:
50.44
HBD:
1.0
HBA:
#RotB:
3.0
Source:
PYROVALERONE HYDROCHLORIDE
4
Small molecule
Approved
Unknown
Unknown
Unknown
Monoamine transporters; Norepinephrine & dopamine inhibitor
PYROVALERONE HYDROCHLORIDE
×
Maximum Phase:
4
First Approval:
None
UNII:
Z95Z9C2201
Molecule Type:
Small molecule
Molecular Formula:
C16H24ClNO
Molecular Weight:
281.83
AlogP:
3.44
PSA:
20.31
HBD:
0.0
HBA:
#RotB:
5.0
Source:
DIHYDROSTREPTOMYCIN
4
Small molecule
Approved
Unknown
Unknown
Eye Infections
Unknown
DIHYDROSTREPTOMYCIN
×
Maximum Phase:
4
First Approval:
None
UNII:
P2I6R8W6UA
Molecule Type:
Small molecule
Molecular Formula:
C21H41N7O12
Molecular Weight:
583.6
AlogP:
-7.95
PSA:
334.59
HBD:
15.0
HBA:
#RotB:
9.0
Source:
PROPIOLACTONE
4
Small molecule
Approved
OTHER
IRRIGATION
Unknown
Unknown
PROPIOLACTONE
×
Maximum Phase:
4
First Approval:
None
UNII:
6RC3ZT4HB0
Molecule Type:
Small molecule
Molecular Formula:
C3H4O2
Molecular Weight:
72.06
AlogP:
-0.07
PSA:
26.3
HBD:
0.0
HBA:
#RotB:
0.0
Source:
SATIVEX
4
Small molecule
Approved
Unknown
Unknown
Unknown
Unknown
SATIVEX
×
Maximum Phase:
4
First Approval:
None
UNII:
Molecule Type:
Small molecule
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
EPINEPHRINE BITARTRATE; PRILOCAINE HYDROCHLORIDE
4
Combination
Approved
OTHER
INJECTION
Unknown
Unknown
EPINEPHRINE BITARTRATE; PRILOCAINE HYDROCHLORIDE
×
Maximum Phase:
4
First Approval:
None
UNII:
Molecule Type:
Combination
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
FLUDARABINE
4
Small molecule
Approved
Unknown
Unknown
Unknown
Unknown
FLUDARABINE
×
Maximum Phase:
4
First Approval:
None
UNII:
Molecule Type:
Small molecule
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
MERSALYL
4
Small molecule
Approved
Unknown
Unknown
Unknown
Unknown
MERSALYL
×
Maximum Phase:
4
First Approval:
None
UNII:
5X1IO031V8
Molecule Type:
Small molecule
Molecular Formula:
C13H16HgNNaO6
Molecular Weight:
505.85
AlogP:
None
PSA:
None
HBD:
None
HBA:
#RotB:
None
Source:
AMINO ACIDS; DEXTROSE; MAGNESIUM CHLORIDE; POTASSIUM PHOSPHATE, DIBASIC; SODIUM ACETATE; SODIUM CHLORIDE
4
Combination
Approved
OTHER
INJECTION
Unknown
Unknown
AMINO ACIDS; DEXTROSE; MAGNESIUM CHLORIDE; POTASSIUM PHOSPHATE, DIBASIC; SODIUM ACETATE; SODIUM CHLORIDE
×
Maximum Phase:
4
First Approval:
None
UNII:
Molecule Type:
Combination
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
PIPERIDOLATE
4
Small molecule
Approved
Unknown
Unknown
Digestive System Diseases
Unknown
PIPERIDOLATE
×
Maximum Phase:
4
First Approval:
None
UNII:
RJO31255V9
Molecule Type:
Small molecule
Molecular Formula:
C21H25NO2
Molecular Weight:
323.44
AlogP:
3.85
PSA:
29.54
HBD:
0.0
HBA:
#RotB:
5.0
Source:
CODEINE PHOSPHATE; PHENYLEPHRINE HYDROCHLORIDE; PROMETHAZINE HYDROCHLORIDE
4
Combination
Approved
OTHER
ORAL
Unknown
Unknown
CODEINE PHOSPHATE; PHENYLEPHRINE HYDROCHLORIDE; PROMETHAZINE HYDROCHLORIDE
×
Maximum Phase:
4
First Approval:
None
UNII:
Molecule Type:
Combination
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
NEUROBLOC
4
Unknown
Approved
Unknown
Unknown
Unknown
Unknown
NEUROBLOC
×
Maximum Phase:
4
First Approval:
None
UNII:
Molecule Type:
Unknown
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
LOBEGLITAZONE
4
Small molecule
Approved
Unknown
Unknown
Diabetes Mellitus; Diabetes Mellitus, Type 2
Unknown
LOBEGLITAZONE
×
Maximum Phase:
4
First Approval:
None
UNII:
MY89F08K5D
Molecule Type:
Small molecule
Molecular Formula:
C24H24N4O5S
Molecular Weight:
480.55
AlogP:
3.69
PSA:
102.88
HBD:
1.0
HBA:
#RotB:
10.0
Source:
1
2
…
256
257
258
259
260
261
262
…
304
305
Next »
Download Option
Close
Header
Compound Name
Maximum Phase
Compound Structure
Smile
Inchi
InchiKey
Compound Properties
Molecular Formula
Molecular Weight
ALogP
PSA